173 related articles for article (PubMed ID: 24824038)
21. The association of fatty acids with prostate cancer risk.
Newcomer LM; King IB; Wicklund KG; Stanford JL
Prostate; 2001 Jun; 47(4):262-8. PubMed ID: 11398173
[TBL] [Abstract][Full Text] [Related]
22. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence.
Astorg P
Cancer Causes Control; 2004 May; 15(4):367-86. PubMed ID: 15141138
[TBL] [Abstract][Full Text] [Related]
23. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
[TBL] [Abstract][Full Text] [Related]
24. Active surveillance for the management of prostate cancer in a contemporary cohort.
Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR
Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of a cell-cycle progression score in men with prostate cancer managed with active surveillance after MRI-guided prostate biopsy--a pilot study.
Arsov C; Jankowiak F; Hiester A; Rabenalt R; Quentin M; Schimmöller L; Blondin D; Antoch G; Albers P
Anticancer Res; 2014 May; 34(5):2459-66. PubMed ID: 24778061
[TBL] [Abstract][Full Text] [Related]
26. Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma.
Godley PA; Campbell MK; Miller C; Gallagher P; Martinson FE; Mohler JL; Sandler RS
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):115-9. PubMed ID: 8850272
[TBL] [Abstract][Full Text] [Related]
27. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
28. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.
Harris WS; Sands SA; Windsor SL; Ali HA; Stevens TL; Magalski A; Porter CB; Borkon AM
Circulation; 2004 Sep; 110(12):1645-9. PubMed ID: 15353491
[TBL] [Abstract][Full Text] [Related]
29. Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.
Al Otaibi M; Ross P; Fahmy N; Jeyaganth S; Trottier H; Sircar K; Bégin LR; Souhami L; Kassouf W; Aprikian A; Tanguay S
Cancer; 2008 Jul; 113(2):286-92. PubMed ID: 18484590
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.
Harris WS; Pottala JV; Varvel SA; Borowski JJ; Ward JN; McConnell JP
Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):257-63. PubMed ID: 23375840
[TBL] [Abstract][Full Text] [Related]
31. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.
Brown I; Wahle KW; Cascio MG; Smoum-Jaouni R; Mechoulam R; Pertwee RG; Heys SD
Prostaglandins Leukot Essent Fatty Acids; 2011 Dec; 85(6):305-10. PubMed ID: 21995886
[TBL] [Abstract][Full Text] [Related]
33. Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.
Liang P; Henning SM; Schokrpur S; Wu L; Doan N; Said J; Grogan T; Elashoff D; Cohen P; Aronson WJ
Prostate; 2016 Oct; 76(14):1293-302. PubMed ID: 27338236
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics.
Krakowsky Y; Loblaw A; Klotz L
J Urol; 2010 Jul; 184(1):131-5. PubMed ID: 20478589
[TBL] [Abstract][Full Text] [Related]
35. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.
Berquin IM; Min Y; Wu R; Wu J; Perry D; Cline JM; Thomas MJ; Thornburg T; Kulik G; Smith A; Edwards IJ; D'Agostino R; Zhang H; Wu H; Kang JX; Chen YQ
J Clin Invest; 2007 Jul; 117(7):1866-75. PubMed ID: 17607361
[TBL] [Abstract][Full Text] [Related]
36. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD.
Sala-Vila A; Harris WS; Cofán M; Pérez-Heras AM; Pintó X; Lamuela-Raventós RM; Covas MI; Estruch R; Ros E
Br J Nutr; 2011 Aug; 106(3):425-31. PubMed ID: 21450116
[TBL] [Abstract][Full Text] [Related]
37. Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
Campbell RA; Li J; Malone L; Levy DA
Urology; 2021 Sep; 155():110-116. PubMed ID: 34144071
[TBL] [Abstract][Full Text] [Related]
38. Repeat prostate biopsies predict location of index cancer in an active surveillance cohort.
Tseng KS; Landis P; Brimo F; Partin AW; Epstein JI; Carter HB
BJU Int; 2011 Nov; 108(9):1415-20. PubMed ID: 21443654
[TBL] [Abstract][Full Text] [Related]
39. Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors.
Shelton PQ; Ivanowicz AN; Wakeman CM; Rydberg MG; Norton J; Riggs SB; Teigland CM
Urology; 2013 May; 81(5):979-84. PubMed ID: 23523297
[TBL] [Abstract][Full Text] [Related]
40. Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages.
Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Cohen P; Aronson WJ
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):127-135. PubMed ID: 31439889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
